Drug use review definition

Drug use review means the programs designed to measure and assess on a retrospective and a prospective basis, through an evaluation of claims data, the proper utilization, quantity, appropriateness as therapy and medical necessity of prescribed medication in the medical assistance program.
Sample 1Sample 2Sample 3
Drug use review means the programs designed to measure and assess on a retro-
Sample 1Sample 2Sample 3
Drug use review means a program as described in 42 U.S.C. 1396r-8(g)(2).
Sample 1Sample 2Sample 3

Examples of Drug use review in a sentence

  • Oral prescription drug orders shall be communicated directly to a pharmacist.9.18(5) Drug use review.

  • WSR 07-20-049, § 388-530-3200, filed9/26/07, effective 11/1/07.] QUALITY OF CARE WAC 182-530-4000 Drug use review (DUR) board.

  • Drug use review board and appeals.1. The department shall implement a prospective and retrospective drug use review program for outpatient prescription drugs and determine which drugs shall be subject to prior authorization before payment will be approved.

  • The addition reads as follows:§ 456.703 Drug use review programs.* * * * *(h) Minimum standards for DUR programs.

  • QUALITY OF CARE NEW SECTIONWAC 388-530-4000 Drug use review (DUR) board.

  • WSR 07-20-049, § 388-530-3200,filed 9/26/07, effective 11/1/07.] QUALITY OF CARE WAC 182-530-4000 Drug use review (DUR) board.

  • The DUR Board membership includes health professionals (on-third licensed actively practicing pharmacists and one-third but no more than 51 percent licensed and actively practicing physicians) with knowledge and experience in one or more of the following:- Clinically appropriate prescribing of covered outpatient drugs- Clinically appropriate dispensing and monitoring of covered outpatient drugs- Drug use review, evaluation, and intervention- Medical quality assurance1927(g)(3)(C)42 CFR 456.716(d)3.

  • The clinically appropriate prescribing of covered outpatient drugs.2. The clinically appropriate dispensing and monitoring of covered outpatient drugs.3. Drug use review, evaluation, and intervention.4. Medical quality assurance.

  • AMENDATORY SECTION (Amending WSR 11-14-075,filed 6/30/11, effective 7/1/11)WAC 182-530-4000 Drug use review (DUR) board.

  • Members are appointed by the Secretary of MDH and serve terms of 3 years from the date of their appointment with the option to serve an additional 3-year term.The membership of the Maryland DUR Board includes health care professionals who have recognized knowledge and expertise in one or more of the following areas:(1) The clinically appropriate prescribing of outpatient drugs.(2) The clinically appropriate dispensing and monitoring of outpatient drugs.(3) Drug use review, evaluation, and intervention.


More Definitions of Drug use review

Drug use review means the programs designed to measure and assess on a retrospective
Sample 1

Related to Drug use review

  • Clinical laboratory means a facility for the microbiological, serological, chemical, hematological, radiobioassay, cytological, immunohematological, pathological, or other examination of materials derived from the human body for the purpose of providing information for the diagnosis, prevention, or treatment of a disease or assessment of a medical condition.

  • Phase I Clinical Study means, as to a particular Licensed Product, an initial clinical study in humans with the purpose of assessing the Licensed Product’s safety, tolerability, toxicity, pharmacokinetics or other pharmacological properties.

  • Clinical review criteria means the written screening procedures, decision abstracts, clinical protocols, and practice guidelines used by a health carrier to determine the necessity and appropriateness of health care services.

  • Participating Clinical Laboratory means a Clinical Laboratory which has a written agreement with the Claim Administrator or another Blue Cross and/or Blue Shield Plan to provide services to you at the time services are rendered.

  • Drug utilization review means an evaluation of a prescription drug order and patient records for

  • Application Review Start Date means the later date of either the date on which the District issues its written notice that the Applicant has submitted a completed Application or the date on which the Comptroller issues its written notice that the Applicant has submitted a completed Application and as further identified in Section 2.3.A of this Agreement.

  • Phase 2 Clinical Trial means a human clinical trial, for which the primary endpoints include a determination of dose ranges or an indication of efficacy in patients being studied as described in 21 C.F.R. §312.21(b), or an equivalent clinical trial in a country in the Territory other than the United States.

  • Drug use test means a scientifically substantiated method to test for the presence of illegal or performance-enhancing drugs or the metabolites thereof in a person’s urine.

  • Phase II Clinical Study means a human clinical study of a product initiated to determine the safety and efficacy in the target patient population, as described 21 C.F.R. 312.21(b).

  • Clinical Study means a Phase I Study, Phase II Study, Phase III Study, as applicable.

  • Phase III Clinical Study means a human clinical study of a product on a sufficient number of subjects that is designed to establish that such product is safe and efficacious for its intended use, and to determine warnings, precautions, and adverse reactions that are associated with such product in the dosage range to be prescribed, which trial is intended to support Regulatory Approval of such product, as described in 21 C.F.R. 312.21(c). 1.185. [***] 1.186. [***]

  • Approved clinical trial means a phase I, phase II, phase III, or phase IV clinical trial that is conducted in relation to the prevention, detection, or treatment of cancer or other life-threatening disease or Condition and is described in any of the following:

  • Phase 3 Clinical Trial means a pivotal clinical trial in humans performed to gain evidence with statistical significance of the efficacy of a product in a target population, and to obtain expanded evidence of safety for such product that is needed to evaluate the overall benefit-risk relationship of such product, to form the basis for approval of an NDA and to provide an adequate basis for physician labeling, as described in 21 C.F.R. § 312.21(c) or the corresponding regulation in jurisdictions other than the United States.

  • Participating Certified Clinical Nurse Specialist means a Certified Clinical Nurse Specialist who has a written agreement with the Claim Administrator or another Blue Cross and/or Blue Shield Plan to provide services to you at the time services are rendered.

  • Non-Participating Certified Clinical Nurse Specialist means a Certified Clinical Nurse Specialist who does not have a written agreement with the Claim Administrator or another Blue Cross and/or Blue Shield Plan to provide services to you at the time services are rendered.

  • Development Plan has the meaning set forth in Section 3.2.

  • Drug test means a test designed to detect the illegal use of a controlled substance.

  • Clinical nurse specialist means a registered nurse with relevant post-basic qualifications and 12 months’ experience working in the clinical area of his/her specified post-basic qualification, or a minimum of four years’ post-basic registration experience, including three years’ experience in the relevant specialist field and who satisfies the local criteria.